Summary: Recent studies suggest a connection between COVID-19 infections, vaccinations, and urinary and prostatic complications. A Hong Kong study found that men with pre-existing lower urinary tract symptoms who had a COVID-19 infection were at a higher risk of developing an enlarged prostate, leading to increased chances of urinary tract infections, urine retention, and hematuria. The virus’s presence in reproductive organs, particularly in the prostate, may contribute to inflammation and related complications.
Reports indicate urinary symptoms such as incontinence, urinary tract diseases, urinating hesitancy, and frequent urination post-COVID infections or vaccinations. Enlarged prostates, potentially triggered by inflammation in the genito-urological area due to SARS-CoV-2, can impede urine flow, causing additional complications.
Some doctors suggest that persistent spike proteins from vaccines may contribute to damage, as biodistribution studies show mRNA vaccines segregating in reproductive organs. Urinary proteins involved in immune response have been found to change before and after COVID-19 vaccination.
Urinary incontinence, a common side effect post-vaccination, is reported more in females than males. The issue has raised concerns, with some attributing it to suppressed immune systems leading to urinary tract infections. The use of ivermectin as a treatment option has been mentioned by psychiatrists treating such patients.
Studies have also linked both SARS-CoV-2 infection and vaccinations to a slight increase in prostate serum antigen (PSA), with the third anti-COVID vaccine dose having a more prominent impact. Elevated PSA levels may serve as an indicator for prostate cancer, though the clinical significance is not fully understood. Some patients in remission for years reportedly developed new-onset prostate cancer post-vaccination, while unvaccinated but infected patients did not experience the same outcome.